Only 41% of cancer survivors tested for HIV
the ONA take:
According to a new study published in the journal Preventing Chronic Disease, only 41% of cancer survivors in the United States under the age of 65 reported ever having a human immunodeficiency virus (HIV) test. Patients are typically tested for HIV when they are diagnosed with cancer or their cancer recurs in order to better coordinate cancer and HIV treatment and improve patient outcomes.
Until now, there has been no published data surrounding the proportion of cancer survivors in the United States who are tested for HIV. For the study, researchers analyzed data from the 2009 Behavioral Risk Factor Surveillance System to determine who had been tested for HIV and to identify factors associated with having had HIV testing.
Of the 41% of cancer survivors who had been tested, 72.2% were aged 25 to 34 years, 59.5% were non-Hispanic blacks, and 51.2% were cervical cancer survivors.
The highest proportion of cancer survivors tested for HIV were from Washington, D.C., and the lowest proportion were from Nebraska. Analyses showed cancer survivors were more likely to be tested for HIV if they were non-Hispanic black or Hispanic, younger, educated, not married or living with a partner, not disabled, and concerned about medical costs. Females, but not males, were more likely to be tested if they had an autoimmunodeficiency syndrome (AIDS)-defining illness.
Only 41% of cancer survivors in the U.S. under 65 reported ever having a HIV test.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|